{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T01:39:09Z","timestamp":1792201149871,"version":"4.4.0"},"reference-count":50,"publisher":"Oxford University Press (OUP)","issue":"2","license":[{"start":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:00:00Z","timestamp":1771459200000},"content-version":"vor","delay-in-days":18,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>This study aimed to assess current clinical practices in the diagnosis and management of atrial fibrillation (AF) among patients with active cancer or a history of cancer therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>A 25-item, physician-based survey was developed by the European Heart Rhythm Association in collaboration with the European Society of Cardiology Council of Cardio-Oncology and the International Cardio-Oncology Society. The survey was disseminated electronically. A total of 380 participants from 74 countries completed the questionnaire, with respondents primarily working as electrophysiologists (30%), general cardiologists (25%), and cardio-oncologists (22%). Nearly two-thirds reported that active cancer \u2018definitely\u2019 or \u2018most probably\u2019 influenced clinical decisions regarding AF diagnosis and management. When AF was diagnosed, rhythm control was the preferred management strategy for symptomatic patients, while rate control was favoured for asymptomatic individuals. A little over 40% reported that a history of cancer therapy \u2018definitely\u2019 or \u2018most probably\u2019 influenced clinical decisions regarding AF. The rhythm control was the most common strategy (40%). In both populations, opportunistic screening for AF and direct oral anticoagulants (DOACs) were preferred strategies. A high level of uncertainty was noted concerning the role of invasive treatment options.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The survey revealed that, despite the lack of robust evidence specific to this patient cohort, contemporary treatment of AF in patients with active cancer or a history of cancer therapy generally follows guidelines developed for the broader AF population. These findings highlight the urgent need for more dedicated data to inform clinical decision-making in cardio-oncology patients with AF.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/europace\/euaf325","type":"journal-article","created":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:58:23Z","timestamp":1771487903000},"source":"Crossref","is-referenced-by-count":3,"title":["Contemporary management of atrial fibrillation in patients with cancer\u2014the 2025 European Heart Rhythm Association survey"],"prefix":"10.1093","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1673-7712","authenticated-orcid":false,"given":"Michal M","family":"Farkowski","sequence":"first","affiliation":[{"name":"Department of Cardiology, Ministry of Interior and Administration National Medical Institute , Wo\u0142oska 137, Warsaw 02-507 ,","place":["Poland"]},{"name":"II Department of Heart Arrhythmia, National Institute of Cardiology , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3075-1943","authenticated-orcid":false,"given":"Sebastian","family":"Szmit","sequence":"additional","affiliation":[{"name":"Department of Cardio-Oncology, Chair of Haematology and Transfusion Medicine, Centre of Postgraduate Medical Education , Warsaw ,","place":["Poland"]},{"name":"Cardio-Oncology Unit, Maria Sklodowska-Curie National Research Institute of Oncology , Warsaw ,","place":["Poland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9820-4815","authenticated-orcid":false,"given":"Giuseppe","family":"Boriani","sequence":"additional","affiliation":[{"name":"Cardiology Division, Department of Biomedical, Metabolic and Neural Sciences, University of Modena and Reggio Emilia, Policlinico di Modena , Modena ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8032-2004","authenticated-orcid":false,"given":"Sergio","family":"Castrejon","sequence":"additional","affiliation":[{"name":"Department of Cardiology, La Paz University Hospital , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8352-8975","authenticated-orcid":false,"given":"Michael","family":"Fradley","sequence":"additional","affiliation":[{"name":"Thalheimer Centre for Cardio-Oncology, Division of Cardiology, Perelman School of Medicine, University of Pennsylvania , Philadelphia, PA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0253-1174","authenticated-orcid":false,"given":"Avirup","family":"Guha","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Program, Medical College of Georgia at Augusta University , Augusta, GA ,","place":["USA"]},{"name":"Division of Cardiology, Department of Medicine, Medical College of Georgia at Augusta University , Augusta, GA ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1737-1903","authenticated-orcid":false,"given":"Jos\u00e8 L","family":"Merino","sequence":"additional","affiliation":[{"name":"Department of Cardiology, La Paz University Hospital , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4733-9418","authenticated-orcid":false,"given":"Giacomo","family":"Mugnai","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Cardio-Thoracic Department, University Hospital of Verona , Verona ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6385-8600","authenticated-orcid":false,"given":"Geraldine A","family":"Lee","sequence":"additional","affiliation":[{"name":"Catherine McAuley School of Nursing & Midwifery, Brookfield Health Sciences Complex, University College Cork , Cork ,","place":["Ireland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8026-840X","authenticated-orcid":false,"given":"Alexander R","family":"Lyon","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Centre of Excellence, Royal Brompton Hospital , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-7221-4829","authenticated-orcid":false,"given":"Diego","family":"Penela","sequence":"additional","affiliation":[{"name":"Humanitas Research Hospital IRCCS , Rozzano, Milan ,","place":["Italy"]},{"name":"Department of Biomedical Sciences, Humanitas University , Pieve Emanuele, Milan ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4322-1183","authenticated-orcid":false,"given":"Laura","family":"Perrotta","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Arrhythmia Unit, Careggi University Hospital , Florence ,","place":["Italy"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3414-7022","authenticated-orcid":false,"given":"Teresa","family":"Lopez-Fernandez","sequence":"additional","affiliation":[{"name":"Cardio-Oncology Unit, Cardiology Department, La Paz University Hospital, IdiPAZ Research Institute , Madrid ,","place":["Spain"]},{"name":"Cardio-Oncology Unit, Cardiology Department, Quironsalud University Hospital , Madrid ,","place":["Spain"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2355-6015","authenticated-orcid":false,"given":"Julian K R","family":"Chun","sequence":"additional","affiliation":[{"name":"Cardioangiologisches Centrum Bethanien, Agaplesion Markus Krankenhaus , Frankfurt am Main ,","place":["Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,2,19]]},"reference":[{"key":"2026021902581546200_euaf325-B1","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC Guidelines for the management of atrial fibrillation developed in collaboration with the European association for cardio-thoracic surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021902581546200_euaf325-B2","doi-asserted-by":"crossref","first-page":"euae195","DOI":"10.1093\/europace\/euae195","article-title":"Global burden of atrial fibrillation\/atrial flutter and its attributable risk factors from 1990 to 2021","volume":"26","author":"Cheng","year":"2024","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B3","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/eurheartj\/ehae222","article-title":"Coexisting atrial fibrillation and cancer: time trends and associations with mortality in a nationwide Dutch study","volume":"45","author":"Chen","year":"2024","journal-title":"Eur Heart J"},{"key":"2026021902581546200_euaf325-B4","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/eurheartj\/ehab745","article-title":"Incidence, risk factors, and mortality of atrial fibrillation in breast cancer: a SEER-medicare analysis","volume":"43","author":"Guha","year":"2022","journal-title":"Eur Heart J"},{"key":"2026021902581546200_euaf325-B5","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022 ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology And Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS).","volume":"43","author":"Lyon","year":"2022","journal-title":"Euro Heart J"},{"key":"2026021902581546200_euaf325-B6","doi-asserted-by":"crossref","first-page":"8985273","DOI":"10.1155\/2019\/8985273","article-title":"Association of cancer and the risk of developing atrial fibrillation: a systematic review and meta-analysis","volume":"2019","author":"Yuan","year":"2019","journal-title":"Cardiol Res Pract"},{"key":"2026021902581546200_euaf325-B7","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s11739-022-03156-w","article-title":"Bleeding and thrombotic events in atrial fibrillation patients with cancer: a systematic review and meta-analysis","volume":"18","author":"Pastori","year":"2023","journal-title":"Intern Emerg Med"},{"key":"2026021902581546200_euaf325-B8","doi-asserted-by":"crossref","first-page":"102974","DOI":"10.1016\/j.cpcardiol.2024.102974","article-title":"Clinical profile and cardiovascular events in patients with atrial fibrillation and hematologic malignancies with recent initiation of targeted therapy: real-life data from CANAC-FA registry","volume":"50","author":"Piserra L\u00f3pez-Fern\u00e1ndez De Heredia","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"2026021902581546200_euaf325-B9","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1161\/CIR.0000000000000986","article-title":"Recognition, prevention, and management of arrhythmias and autonomic disorders in cardio-oncology: a scientific statement from the American Heart Association","volume":"144","author":"Fradley","year":"2021","journal-title":"Circulation"},{"key":"2026021902581546200_euaf325-B10","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.33963\/v.kp.96840","article-title":"A practical approach to the 2022 ESC cardio-oncology guidelines: comments by a team of experts - cardiologists and oncologists","volume":"81","author":"Leszek","year":"2023","journal-title":"Kardiol Pol"},{"key":"2026021902581546200_euaf325-B11","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jaccao.2022.08.014","article-title":"Arterial thromboembolism in patients with AF and CHA(2)DS(2)-VASc score 0-2 with and without cancer","volume":"5","author":"Leader","year":"2023","journal-title":"JACC CardioOncol"},{"key":"2026021902581546200_euaf325-B12","doi-asserted-by":"crossref","first-page":"euae298","DOI":"10.1093\/europace\/euae298","article-title":"Spotlight on the 2024 ESC\/EACTS management of atrial fibrillation guidelines: 10 novel key aspects","volume":"26","author":"Rienstra","year":"2024","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B13","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1056\/NEJMoa2019422","article-title":"Early rhythm-control therapy in patients with atrial fibrillation","volume":"383","author":"Kirchhof","year":"2020","journal-title":"N Engl J Med"},{"key":"2026021902581546200_euaf325-B14","doi-asserted-by":"crossref","first-page":"e023391","DOI":"10.1161\/JAHA.121.023391","article-title":"Risks and benefits of early rhythm control in patients with acute strokes and atrial fibrillation: a multicenter, prospective, randomized study (the RAFAS trial)","volume":"11","author":"Park","year":"2022","journal-title":"J Am Heart Assoc"},{"key":"2026021902581546200_euaf325-B15","doi-asserted-by":"crossref","first-page":"oeae058","DOI":"10.1093\/ehjopen\/oeae058","article-title":"Catheter ablation for atrial fibrillation and impact on clinical outcomes","volume":"4","author":"Providencia","year":"2024","journal-title":"Eur Heart J Open"},{"key":"2026021902581546200_euaf325-B16","doi-asserted-by":"crossref","first-page":"e040908","DOI":"10.1161\/JAHA.125.040908","article-title":"Early rhythm control of atrial fibrillation in cancer survivors: a nationwide population-based study","volume":"14","author":"Han","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"2026021902581546200_euaf325-B17","doi-asserted-by":"crossref","first-page":"euad263","DOI":"10.1093\/europace\/euad263","article-title":"Outcomes and readmissions in patients with cancer undergoing catheter ablation for atrial fibrillation","volume":"25","author":"Agarwal","year":"2023","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10840-023-01677-8","article-title":"Safety and efficacy of catheter ablation for atrial fibrillation in cancer survivors: a systematic review and meta-analysis","volume":"67","author":"Costa","year":"2023","journal-title":"J Interv Card Electrophysiol"},{"key":"2026021902581546200_euaf325-B19","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s40959-023-00171-4","article-title":"Efficacy and safety of catheter ablation for atrial fibrillation in patients with history of cancer","volume":"9","author":"Ganatra","year":"2023","journal-title":"Cardio-oncology (London, England)"},{"key":"2026021902581546200_euaf325-B20","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1111\/pace.14830","article-title":"Outcome of cancer patients after atrial fibrillation ablation: insights from the China-AF registry","volume":"46","author":"Peng","year":"2023","journal-title":"Pacing Clin Electrophysiol"},{"key":"2026021902581546200_euaf325-B21","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.athoracsur.2009.04.074","article-title":"A randomized trial evaluating amiodarone for prevention of atrial fibrillation after pulmonary resection","volume":"88","author":"Tisdale","year":"2009","journal-title":"Ann Thorac Surg"},{"key":"2026021902581546200_euaf325-B22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.6004\/jnccn.2014.0005","article-title":"Survivorship: introduction and definition. Clinical practice guidelines in oncology","volume":"12","author":"Denlinger","year":"2014","journal-title":"J Natl Compr Canc Netw"},{"key":"2026021902581546200_euaf325-B23","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1111\/jth.14219","article-title":"Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH","volume":"16","author":"Khorana","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2026021902581546200_euaf325-B24","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/eurjpc\/zwaa054","article-title":"Anticoagulation in patients with atrial fibrillation and active cancer: an international survey on patient management","volume":"28","author":"Boriani","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"2026021902581546200_euaf325-B25","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1093\/europace\/euac136","article-title":"The challenge of managing multimorbid atrial fibrillation: a pan-European European heart rhythm association (EHRA) member survey of current management practices and clinical priorities","volume":"24","author":"Lee","year":"2022","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B26","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1177\/2047487318759858","article-title":"CHA(2)DS(2)-VASc score and risk of thromboembolism and bleeding in patients with atrial fibrillation and recent cancer","volume":"25","author":"D'Souza","year":"2018","journal-title":"Eur J Prev Cardiol"},{"key":"2026021902581546200_euaf325-B27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.jaccao.2020.09.008","article-title":"Patterns of anticoagulation use in patients with cancer with atrial fibrillation and\/or atrial flutter","volume":"2","author":"Fradley","year":"2020","journal-title":"JACC CardioOncol"},{"key":"2026021902581546200_euaf325-B28","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1093\/europace\/euab065","article-title":"2021 European Heart Rhythm Association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation","volume":"23","author":"Steffel","year":"2021","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B29","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.amjcard.2023.06.068","article-title":"Left atrial appendage closure outcomes in patients with cancer at a single tertiary center","volume":"202","author":"Kumar","year":"2023","journal-title":"Am J Cardiol"},{"key":"2026021902581546200_euaf325-B30","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.3390\/jcm13216514","article-title":"Left atrial appendage closure in atrial fibrillation patients with cancer","volume":"13","author":"Zweiker","year":"2024","journal-title":"J Clin Med"},{"key":"2026021902581546200_euaf325-B31","doi-asserted-by":"crossref","first-page":"euae035","DOI":"10.1093\/europace\/euae035","article-title":"Practical guide on left atrial appendage closure for the non-implanting physician: an international consensus paper","volume":"26","author":"Potpara","year":"2024","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1093\/ehjdh\/ztae082","article-title":"Mobile\/wearable digital devices for care of active cancer patients: a survey from the ESC council of cardio-oncology","volume":"6","author":"Boriani","year":"2025","journal-title":"Eur Heart J Digit Health"},{"key":"2026021902581546200_euaf325-B33","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1016\/j.cvdhj.2022.08.002","article-title":"Wearable device use and technology preferences in cancer survivors with or at risk for atrial fibrillation","volume":"3","author":"Faro","year":"2022","journal-title":"Cardiovasc Digit Health J"},{"key":"2026021902581546200_euaf325-B34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s40959-023-00180-3","article-title":"Atrial fibrillation in cancer survivors - a systematic review and meta-analysis","volume":"9","author":"Bao","year":"2023","journal-title":"Cardio-oncology (London, England)"},{"key":"2026021902581546200_euaf325-B35","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1161\/CIRCULATIONAHA.121.058911","article-title":"Consumer-led screening for atrial fibrillation: frontier review of the AF-SCREEN international collaboration","volume":"146","author":"Brandes","year":"2022","journal-title":"Circulation"},{"key":"2026021902581546200_euaf325-B36","doi-asserted-by":"crossref","first-page":"euaf076","DOI":"10.1093\/europace\/euaf076","article-title":"Practical compendium of antiarrhythmic drugs: a clinical consensus statement of the European Heart Rhythm Association of the European Society of Cardiology","volume":"27","author":"Merino","year":"2025","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B37","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.cjco.2020.09.013","article-title":"Chronic amiodarone use and the risk of cancer: a systematic review and meta-analysis","volume":"3","author":"Siemers","year":"2021","journal-title":"CJC Open"},{"key":"2026021902581546200_euaf325-B38","doi-asserted-by":"crossref","first-page":"e011585","DOI":"10.1161\/CIRCEP.122.011585","article-title":"Outcomes of early rhythm control therapy in patients with atrial fibrillation and a high comorbidity burden in large real-world cohorts","volume":"16","author":"Dickow","year":"2023","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026021902581546200_euaf325-B39","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1161\/CIRCULATIONAHA.122.060274","article-title":"Early rhythm control in patients with atrial fibrillation and high comorbidity burden","volume":"146","author":"Rillig","year":"2022","journal-title":"Circulation"},{"key":"2026021902581546200_euaf325-B40","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1186\/s12916-022-02545-4","article-title":"Effectiveness of early rhythm control in improving clinical outcomes in patients with atrial fibrillation: a systematic review and meta-analysis","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med"},{"key":"2026021902581546200_euaf325-B41","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/ehjqcco\/qcaa039","article-title":"Shared decision-making: the patient on the forefront of care coordination","volume":"6","author":"Hendriks","year":"2020","journal-title":"Eur Heart J Qual Care Clin Outcomes"},{"key":"2026021902581546200_euaf325-B42","doi-asserted-by":"crossref","first-page":"euaf124","DOI":"10.1093\/europace\/euaf124","article-title":"Arrhythmia care in ESC member countries: the 2025 ESC-EHRA atlas on heart rhythm disorders","volume":"27","author":"Farkowski","year":"2025","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B43","doi-asserted-by":"crossref","first-page":"euae043","DOI":"10.1093\/europace\/euae043","article-title":"2024 European Heart Rhythm Association\/Heart Rhythm Society\/Asia Pacific Heart Rhythm Society\/Latin American heart rhythm society expert consensus statement on catheter and surgical ablation of atrial fibrillation","volume":"26","author":"Tzeis","year":"2024","journal-title":"Europace"},{"key":"2026021902581546200_euaf325-B44","first-page":"S1547-5271(25)02445-2","article-title":"Ablation of atrial fibrillation and risk of stroke: a meta-analysis","volume":"19","author":"Providencia","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026021902581546200_euaf325-B45","doi-asserted-by":"crossref","first-page":"3669","DOI":"10.3390\/jcm10163669","article-title":"Safety and efficacy of cryoballoon based pulmonary vein isolation in patients with atrial fibrillation and a history of cancer","volume":"10","author":"Eitel","year":"2021","journal-title":"J Clin Med"},{"key":"2026021902581546200_euaf325-B46","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s10840-022-01341-7","article-title":"Mediastinal radiation therapy for breast cancer in female patients is an independent risk factor for atrial fibrillation recurrence post-catheter ablation","volume":"65","author":"Haq","year":"2022","journal-title":"J Interv Card Electrophysiol"},{"key":"2026021902581546200_euaf325-B47","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1080\/00015385.2020.1812892","article-title":"Absence of detectable effect of radiotherapy and chemotherapy for breast cancer on the presence of low voltage areas in patients receiving left atrial catheter ablation","volume":"76","author":"Hashiguchi","year":"2021","journal-title":"Acta Cardiol"},{"key":"2026021902581546200_euaf325-B48","doi-asserted-by":"crossref","first-page":"537","DOI":"10.33963\/v.phj.99679","article-title":"A pilot study of high-density mapping of left atrial scarring in patients with a history of cancer treatment undergoing ablation of arrhythmia: the pilot OncoLA study","volume":"82","author":"Farkowski","year":"2024","journal-title":"Kardiol Pol"},{"key":"2026021902581546200_euaf325-B49","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ejhf.3102","article-title":"European society of cardiology core curriculum for cardio-oncology","volume":"26","author":"Lopez-Fernandez","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026021902581546200_euaf325-B50","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s40959-025-00304-x","article-title":"Nursing knowledge in cardio-oncology: results of an international learning needs-assessment survey","volume":"11","author":"Fadol","year":"2025","journal-title":"Cardio-oncology (London, England)"}],"container-title":["Europace"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/2\/euaf325\/66988199\/euaf325.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/europace\/article-pdf\/28\/2\/euaf325\/66988199\/euaf325.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T07:58:30Z","timestamp":1771487910000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/europace\/article\/doi\/10.1093\/europace\/euaf325\/8490154"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2,3]]}},"URL":"https:\/\/doi.org\/10.1093\/europace\/euaf325","relation":{},"ISSN":["1099-5129","1532-2092"],"issn-type":[{"value":"1099-5129","type":"print"},{"value":"1532-2092","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2026,2]]},"article-number":"euaf325"}}